Treatment of high stress Other
Conditions
Sponsors
Università di Bologna - Dipartimento di Scienze e Tecnologie AgroAlimenatri (DISTAL)
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Between the ages of 18 – 75 years 2. Comply with eligibility criteria to access and take part on the evaluated intervention 3. Stress interference in daily life being significantly or very significantly (as assessed by the screening questionnaire) 4. Either: often or very often experiences of discrimination or prejudices in daily life OR Yes experiencing persistent poor sleep quality/poor mood/low energy levels/sadness/fatigue/anxiety (as assessed by the screening questionnaire) 5. No previous (last month) or current participation in the same type of nature-based therapy we are evaluating
Exclusion criteria
Exclusion criteria: 1. Intellectual disability (ICD-11 6A00) 2. Phobias that can highly impact the capacity to benefit from our evaluated interventions, such as social and insect-related phobias (ICD-11 6B02, 6B03, 6B04) 3. Dissociative behaviours (ICD-11 6B60, 6B61, 6B62, 6B63, 6B64, 6B65, 6B66, 6E65, 6B6Y, 6B6Z) 4. Mental or behavioural symptoms, signs or clinical findings that can highly impact the capacity of the intervention group to benefit from our evaluated interventions or that increases their potential to become difficult cases to handle by guides (ICD-11 MB23.0, MB23.R, MB23.S)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Screening: Preliminary assessment to determine participant eligibility. Baseline: Data collection at the start of the intervention, before exposure. Follow-up 1: Assessment immediately after the conclusion of the intervention or the "usual care" phase. Follow-up 2: Assessment one month after the end of the intervention. Follow-up 3: Assessment three months after the end of the intervention. 1. Activities performed is measured using a tool developed internally by the team at baseline and Follow-up 1 2. Stress interfering with daily life is measured using a tool developed internally by the team at screening 3. Experiences of discrimination is measured using questions indicated in the General Protocol at screening 4. Experiences of poor mental health is measured using a tool developed internally by the team at screening 5. Perceived stress is measured using the Perceived Stress Scale (PSS-10) from baseline to Follow-up 3 6. Quality of life is measured using the EQ-5D-5L from baseline to Follow-up 3 7. General well-being is measured using the ONS-4 from baseline to Follow-up 3 8. Psychological well-being is measured using the Warwick-Edinburgh Mental Well-being Scale (WEMWBS) from baseline to Follow-up 3 9. Anxiety is measured using the GAD-7 from baseline to Follow-up 3 10. Sleep quality is measured using the Pittsburgh Sleep Quality Index (PSQI - 2) from baseline to Follow-up 3 11. Emotion regulation is measured using the Difficulties in Emotion Regulation Scale (DERS-16) from baseline to Follow-up 3 12. Self-esteem is measured using the Rosenberg Self-Esteem Scale (RSES) from baseline to Follow-up 3 13. Depression is measured using the Patient Health Questionnaire-9 (PHQ-9) at baseline, Follow-up 1, Follow-up 2, and Follow-up 3 14. Cost-utility is measured using the Client Service Receipt Inventory (CSRI) at baseline and Follow-up 3 15. Human–nature connection is measured using a tool developed within WP4 of the GreenMe project at baseline and Follow-up 1 16. Percei | — |
Secondary
| Measure | Time frame |
|---|---|
| There are no secondary outcome measures | — |
Countries
Italy
Contacts
Public ContactGiuseppina Pennisi
Outcome results
None listed